Home  |  Contact
Due to maintenance work, this service and ftp://ftp.expasy.org will be unavailable from Tuesday August 23rd 18:00 until Wednesday August 24th 08:00 CEST. Apologies for the inconvenience.

UniProtKB/Swiss-Prot Q09428: Variant p.Arg1418His

ATP-binding cassette sub-family C member 8
Gene: ABCC8
Variant information

Variant position:  1418
The position of the amino-acid change on the UniProtKB canonical protein sequence.

Type of variant:  LP/P [Disclaimer]
The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance

Residue change:  From Arginine (R) to Histidine (H) at position 1418 (R1418H, p.Arg1418His).
Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.

Physico-chemical properties:  Change from large size and basic (R) to medium size and polar (H)
The physico-chemical property of the reference and variant residues and the change implicated.

BLOSUM score:  0
The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page

Variant description:  In HHF1; altered intracellular trafficking.
Any additional useful information about the variant.

Other resources:  
Links to websites of interest for the variant.

Sequence information

Variant position:  1418
The position of the amino-acid change on the UniProtKB canonical protein sequence.

Protein sequence length:  1581
The length of the canonical sequence.

The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.

Residue conservation: 
The multiple alignment of the region surrounding the variant against various orthologous sequences.




Sequence annotation in neighborhood:  
The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.

Chain 1 – 1581 ATP-binding cassette sub-family C member 8
Topological domain 1298 – 1581 Cytoplasmic
Domain 1344 – 1578 ABC transporter 2
Alternative sequence 51 – 1581 Missing. In isoform 3.
Helix 1418 – 1420

Literature citations

Hyperinsulinism of infancy: novel ABCC8 and KCNJ11 mutations and evidence for additional locus heterogeneity.
Tornovsky S.; Crane A.; Cosgrove K.E.; Hussain K.; Lavie J.; Heyman M.; Nesher Y.; Kuchinski N.; Ben-Shushan E.; Shatz O.; Nahari E.; Potikha T.; Zangen D.; Tenenbaum-Rakover Y.; de Vries L.; Argente J.; Gracia R.; Landau H.; Eliakim A.; Lindley K.; Dunne M.J.; Aguilar-Bryan L.; Glaser B.;
J. Clin. Endocrinol. Metab. 89:6224-6234(2004)
Cited for: VARIANTS HHF1 GLU-70; ARG-111; GLU-1342; HIS-1418 AND TRP-1493; CHARACTERIZATION OF VARIANTS HHF1 GLU-70; ARG-111; GLU-1342; HIS-1418 AND TRP-1493;

Alternating hypoglycemia and hyperglycemia in a toddler with a homozygous p.R1419H ABCC8 mutation: an unusual clinical picture.
Harel S.; Cohen A.S.; Hussain K.; Flanagan S.E.; Schlade-Bartusiak K.; Patel M.; Courtade J.; Li J.B.; Van Karnebeek C.; Kurata H.; Ellard S.; Chanoine J.P.; Gibson W.T.;
J. Pediatr. Endocrinol. Metab. 28:345-351(2015)

Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.